A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2013
11/27/2013	CN103405409A Application of Chukrasone B in medicine for treating ovarian cancer
11/27/2013	CN103405407A Application of compound in preparation of medicines for treating pancreatic cancer
11/27/2013	CN103405406A Application of compound in preparation of medicines for treating endometrial cancer
11/27/2013	CN103405405A Compositions and methods of delivery of pharmacological agents
11/27/2013	CN103405398A Allantoin preparation and application thereof
11/27/2013	CN103405396A Zedoary-cyclic-diolefine-containing pharmaceutical composition and pharmacy application thereof
11/27/2013	CN103405393A Imatinib mesylate pill and preparation method thereof
11/27/2013	CN103405391A BCG polysaccharide nucleic acid freeze-dried powder and preparation method thereof
11/27/2013	CN103405385A Temozolomide intravenous injection fat emulsion and preparation method thereof
11/27/2013	CN103405369A Tooth-protecting toothpaste
11/27/2013	CN102961337B Preparation method of target compound nano particle
11/27/2013	CN102784363B Traditional Chinese medicine composition for treating pancreatic cancer and preparation method thereof
11/27/2013	CN102755354B Fusarium oxysporum extract and application thereof
11/27/2013	CN102753522B Substituted pyrrolidine-2-carboxamides
11/27/2013	CN102743376B Costustoot pharmaceutical composition and medicinal application
11/27/2013	CN102688495B Nano particle carrier having tumor and tumor-associated macrophage targeting multiple functions and preparation thereof
11/27/2013	CN102670935B Method for extracting total saponins from allium chinense
11/27/2013	CN102657872B Multifunctional graphene oxide/ polyamide-amine (PAMAM)/ diethylene triamine pentaacetic-gadolinium (DTPA-Gd)/ prostate stem cell antigen (PSCA) antibody material and preparation method and application thereof
11/27/2013	CN102617391B Resveratrol benzene acrylamide derivative, preparing method and application thereof
11/27/2013	CN102584768B 3-nitro-8-ethyoxyl-2H-chromene compound and preparation method and application thereof
11/27/2013	CN102579511B Method for integrally extracting steroidal compounds, polysaccharides and polyphenols from inonotus obliquus
11/27/2013	CN102574837B Novel 5-fluorouracil derivative
11/27/2013	CN102552869B Three-in-one comprehensive therapy for hysteromyoma
11/27/2013	CN102526566B Chinese medicine preparation for treating hysteromyoma and ovaricyst and preparation method
11/27/2013	CN102526426B Medicine for treating esophageal cancer
11/27/2013	CN102421754B Acrylamide derivative and use thereof in manufacture of medicament
11/27/2013	CN102417514B Pyridine derivatives, preparation method thereof, and purpose thereof
11/27/2013	CN102406694B Anti-tumor effective part of traditional Chinese medicine lespedeza as well as preparation method and application thereof
11/27/2013	CN102329325B Pyrrolopyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitors
11/27/2013	CN102321096B Anticancer compound
11/27/2013	CN102311447B Heterocyclo pyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitor
11/27/2013	CN102219835B Long peptide based on HCA587 antigen and its application in preparing antitumor drugs
11/27/2013	CN102212057B Carboxylic acid non-steroidal anti-inflammatory agent derivative and preparation method and application thereof
11/27/2013	CN102107011B Paramagnetic-upconversion luminous composite nanometer particle, preparation method and application thereof
11/27/2013	CN102014966B Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in treatment of neoplasias
11/27/2013	CN102010420B [(10S)-9,10-dihydroartemisinine-10-oxyl]benzaldehyde semicarbazones (sulfur) series substances as well as preparation method and application thereof
11/27/2013	CN101952287B Protein kinase inhibitors and use thereof
11/27/2013	CN101918362B 吡啶衍生物 Pyridine derivatives
11/27/2013	CN101857588B 4-aromatic aminoquinazoline derivative and purpose thereof
11/27/2013	CN101765591B Pyrimidine derivatives useful for treatment of inflammatory or allergic conditions
11/27/2013	CN101612399B PDGFR-alpha antagonists for treatment of metastatic bone cancer
11/27/2013	CN101511835B 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors
11/26/2013	US8592591 Fused bicyclic imidazoles
11/26/2013	US8592579 Pyrrolotriazine kinase inhibitors
11/26/2013	US8592469 Diazonamide analogs
11/26/2013	US8592433 Compounds and compositions as protein kinase inhibitors
11/26/2013	US8592432 Compounds and compositions as protein kinase inhibitors
11/26/2013	US8592395 Therapeutic compounds
11/26/2013	US8592379 Metastin derivative and use thereof
11/26/2013	US8592169 Tumour marker proteins and uses thereof
11/26/2013	US8592152 Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapy
11/26/2013	US8591950 Hydrogel implants with varying degrees of crosslinking
11/26/2013	US8591897 Anti-ERBB2 antibody adjuvant therapy
11/26/2013	US8591890 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
11/26/2013	CA2593780C The use of alpha-ketoglutarate in the treatment or prophylaxis of neoplastic disease
11/26/2013	CA2590961C [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
11/26/2013	CA2541438C The modulation of hyaluronan synthesis and degradation in the treatment of disease
11/26/2013	CA2532982C Thienopyridine and furopyridine kinase inhibitors
11/26/2013	CA2511538C Immunostimulatory combinations
11/26/2013	CA2450828C Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin
11/26/2013	CA2448971C Chimeric flavivirus vectors
11/26/2013	CA2425072C Wt1 fusion polypeptides and methods for wt1 immunotherapy
11/26/2013	CA2378562C Method for producing oligopolysaccharides
11/26/2013	CA2334850C Novel methods and interferon deficient substrates for the propagation of viruses
11/26/2013	CA2221690C Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
11/21/2013	WO2013173822A1 Constructs for diagnosing and treating inflammatory bowel diseases and colon cancer
11/21/2013	WO2013173605A1 Compositions and methods for modulating pten expression
11/21/2013	WO2013173436A1 Pre-selection of subjects for therapeutic treatment with an hsp90 inhibitor based on hypoxic status
11/21/2013	WO2013173435A1 METHODS AND COMPOSITIONS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR-1α (PGC1α ) AS A TARGET OF CIRCULATING TUMOR CELLS
11/21/2013	WO2013173428A1 Veliparib in combination with whole brain radiation therapy for the treatment of brain metastases
11/21/2013	WO2013173312A1 Using modulators of ccr5 for treating cancer
11/21/2013	WO2013172999A1 Pharmaceutical compositions for the delivery of substantially water-insoluble drugs
11/21/2013	WO2013172933A1 Ethnic gene profile of genes involved in angiogenesis may predict regional bevacizumab efficacy difference in gastric cancer
11/21/2013	WO2013172479A1 Carboxylic acid compounds
11/21/2013	WO2013172421A1 Ampk protein activator screening method, and ampk protein activator
11/21/2013	WO2013171777A2 Use of trop-2 as predictive marker of response to anti-tumor therapy based on inhibitors of cd9, akt and molecules of the tetraspanin signalling network
11/21/2013	WO2013171690A1 Monocyclic heteroaryl cycloalkyldiamine derivatives
11/21/2013	WO2013171684A1 Progesterone receptor modulators for use in preventing or treating androgen mediated diseases
11/21/2013	WO2013171640A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013	WO2013171639A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013	WO2013171473A1 Dosage regimen for sapacitabine and seliciclib
11/21/2013	WO2013171470A1 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof
11/21/2013	WO2013171382A1 Docetaxel-based prolonged-release cancer treatment drug
11/21/2013	WO2013171289A1 Combination of cd37 antibodies with further agents
11/21/2013	WO2013171287A1 Combination of cd37 antibodies with ice (ifosfamide, carboplatin, etoposide)
11/21/2013	WO2013171224A1 Radioactive rhodium complexes, preparation methods and uses thereof
11/21/2013	WO2013170779A1 Pharmaceutical composition comprising anti-vegf antibody
11/21/2013	WO2013170777A1 Use of anti-vefg antibody
11/21/2013	WO2013170774A1 Acetylene derivative having antineoplastic activity
11/21/2013	WO2013170770A1 Acetylene derivatives having antitumor activity
11/21/2013	WO2013170758A1 Fused ring-structured benzamide compound and application thereof as antineoplastic medicament
11/21/2013	WO2013170757A1 4-aminoquinazoline hydroxamic acid compound and application as antineoplastic medicament
11/21/2013	WO2013170756A1 Applications of dopac in preparing antitumor drugs
11/21/2013	WO2013170719A1 Vinorelbine derivatives, pharmaceutical composition, preparation method therefor and application thereof
11/21/2013	WO2013170671A1 Pteridine ketone derivative and applications thereof as egfr, blk, and flt3 inhibitor
11/21/2013	WO2013170637A1 Application of paeoniflorin compound in preparation of antitumor drug
11/21/2013	WO2013170408A1 Tat ptd-endostatin recombinant protein, preparation method and application thereof
11/21/2013	WO2013170379A1 Drug delivery across the blood-brain barrier using magnetically heatable entities
11/21/2013	WO2013170365A1 Compositions of sparc polypeptide and grp78, and methods and uses thereof for sensitizing cancer cells
11/21/2013	WO2013170364A1 Sparc polypeptide and collagen-iv matrix for sensitizing cancer cells to a chemotherapeutic agent

1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 2211